| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |